Israeli medical cannabis company Canonic said it received approval from the Israel Medical Cannabis Agency to start operations. The company said it established growing operations this year to supply seedlings to third-party certified medical cannabis growers in Israel and abroad. Canonic said it is “leading the cannabis industry beyond CBD and other known constituents by mapping the entire cannabis plant genome.” The company plans to begin sales in Israel in 2022.
Like HempToday? How you can support us
Your donations help us to keep HempToday open for all readers, regardless of what they can afford to pay. Through this “information equality” we're able to support hemp entrepreneurs and stakeholders all over the world by keeping a spotlight on hemp and all the promise it offers for economic development and healing our planet.